Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05226_nanopub.RAkm1h2MSInmlA9jXnAN4gZYGg9gG-XHZ_0EKlK4nsZVI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05226 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05226 label "BTA9881 [drugbank:DB05226]" assertion.
- drugbank:DB05226 seeAlso DB05226 assertion.
- drugbank:DB05226 description "BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials." assertion.
- drugbank:DB05226 identifier "drugbank:DB05226" assertion.
- drugbank:DB05226 title "BTA9881" assertion.
- drugbank:DB05226 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05226 drugbank_vocabulary:drugbank-id "DB05226" assertion.
- drugbank:DB05226 bio2rdf_vocabulary:x-identifiers.org DB05226 assertion.
- drugbank:DB05226 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05226" assertion.
- drugbank:DB05226 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05226 bio2rdf_vocabulary:identifier "DB05226" assertion.